ARCT ARCTURUS THERAPEUTICS HOLDINGS INC Investments/Divestments 8-K Filing 2023 - Amendment to Collaboration and License Agreement with Seqirus, Inc. Arcturus Therapeutics Holdings Inc. entered into an amendment to its Collaboration and License Agreement with Seqirus, Inc. for a $17.5 million milestone payment related to the LUNAR-FLU program.Get access to all SEC 8-K filings of the ARCTURUS THERAPEUTICS HOLDINGS INC